Literature DB >> 2533145

Mechanism of LHRH analogue action in uterine fibroids.

R W Shaw1.   

Abstract

Luteinising hormone-releasing hormone analogues have been found to reduce the size of uterine fibroids. Further studies are required to determine their exact mechanism of action. However, they are known to induce hypo-oestrogenism, which leads to reduction in uterine arterial blood flow, one mechanism by which reduction of fibroid size is thought to occur.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2533145     DOI: 10.1159/000181332

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  4 in total

Review 1.  Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.

Authors:  P Chrisp; K L Goa
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

Review 2.  Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders.

Authors:  C M Perry; R N Brogden
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

3.  The role of laparoscopic-assisted myomectomy (LAM).

Authors:  D S Seidman; C H Nezhat; F Nezhat; C Nezhat
Journal:  JSLS       Date:  2001 Oct-Dec       Impact factor: 2.172

Review 4.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.